Showing results (141-150 of 381) with videos related to
Sort By:
Pageof 39
Nature Communications|April 8, 2025
Enabling new insights from old scans by repurposing clinical MRI archives for multiple sclerosis researchPhilipp Goebl, Jed Wingrove, Omar Abdelmannan, et al.Journal of Neurology, Neurosurgery, and Psychiatry|April 21, 2021
Predicting disability progression and cognitive worsening in multiple sclerosis using patterns of grey matter volumesElisa Colato, Jonathan Stutters, Carmen Tur, et al.Neuroimage|February 12, 2017
Machine learning based compartment models with permeability for white matter microstructure imagingGemma L Nedjati-Gilani, Torben Schneider, Matt G Hall, et al.Qualitative Health Research|February 28, 2014
Internalizing motivation to self-care: a multifaceted challenge for young liver transplant recipientsIsabelle Aujoulat, Magda Janssen, France Libion, et al.Neurology(R) Neuroimmunology & Neuroinflammation|November 11, 2021
B Cells in the CNS at Postmortem Are Associated With Worse Outcome and Cell Types in Multiple SclerosisMarcello Moccia, Lukas Haider, Arman Eshaghi, et al.Brain : a Journal of Neurology|August 26, 2015
Reduced gamma-aminobutyric acid concentration is associated with physical disability in progressive multiple sclerosisNiamh Cawley, Bhavana S Solanky, Nils Muhlert, et al.Neurology|March 4, 2025
Investigating Whether Dissemination in Time Is Essential to Diagnose Relapsing Multiple SclerosisWallace J Brownlee, Michael A Foster, Giuseppe Pontillo, et al.Brain Communications|July 30, 2024
Longitudinal network-based brain grey matter MRI measures are clinically relevant and sensitive to treatment effects in multiple sclerosisElisa Colato, Jonathan Stutters, Sridar Narayanan, et al.The Lancet. Neurology|June 20, 2006
Home versus outpatient administration of intravenous steroids for multiple-sclerosis relapses: a randomised controlled trialJeremy Chataway, Bernadette Porter, Afsane Riazi, et al.Lancet (London, England)|November 15, 2003
Cannabinoids for treatment of spasticity and other symptoms related to multiple sclerosis (CAMS study): multicentre randomised placebo-controlled trialJohn Zajicek, Patrick Fox, Hilary Sanders, et al.Pageof 39